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Follow-up of residual shunt after patent
foramen ovale closure
Introduction
Percutaneous closure of patent foramen ovale
(PFO) is advocated to prevent recurrences of
cerebrovascular ischemic events (1), migraine
attacks (2), and to protect divers from the risk of
gasembolitothebrain(3).TheissueofPFOclosure
in symptomatic patients is still debated. This
enforcestheneedforanaccuratepatientmonitoring
after percutaneous PFO closure. In fact, recurrent
thromboembolic events after percutaneous closure
of the PFO have been linked to the persistence of a
communication between the atria (4, 5). A system-
atic evaluation of the effective sealing is therefore
warranted, and transesophageal echocardiography
(TEE) is usually recommended (6).
Contrast-enhanced transcranial Doppler (ce-TCD)
is comparable with contrast TEE for detecting
right-to-left shunts (RLS) as a result of PFO (7, 8).
Anzola et al. (9) have proposed that ce-TCD may
be superior for detecting residual signiﬁcant shunts
after PFO closure.
We report our results of the evaluation of
residual RLS through the interatrial septum
(IAS) after percutaneous closure by ce-TCD, as
compared with contrast TEE, to investigate the
relative merit of the two techniques.
Materials and methods
TEE technique
TEE was performed according to standard practice
guidelines. Esophageal intubation was performed
with the patient in the fasting state and in the left
lateral decubitus position, after premedication with
topical anesthesia and sedation, as clinically indi-
cated. A commercially available ultrasound device
(HP Sonos 1500⁄2500 equipped with an OmniPlane
probe; Philips Medical, Bothel, WA, USA) was
used for cardiac imaging. The heart and thoracic
aorta were scanned for the presence of potential
embolic sources (left atrial or ventricular thrombi,
endocardial vegetations, and aortic plaques).
The IAS was explored primarily in the transverse
midesophageal four-chamber view and the longi-
tudinal biatrial ⁄bicaval view. An aneurysm of the
interatrial septum (ASA) was deﬁned as the
protrusion of the IAS of more than 10 mm
beyond the plane of the IAS (10) or as a phasic
Acta Neurol Scand 2010: 122: 257–261 DOI: 10.1111/j.1600-0404.2009.01302.x Copyright   2009 The Authors
Journal compilation   2009 Blackwell Munksgaard
ACTA NEUROLOGICA
SCANDINAVICA
Orzan F, Liboni W, Bonzano A, Molinari F, Ribezzo M, Rebaudengo
N, Grippi G, Negri E. Follow-up of residual shunt after patent foramen
ovale closure.
Acta Neurol Scand: 2010: 122: 257–261.
 2009 TheAuthorsJournalcompilation 2009 Blackwell Munksgaard.
Objectives – Transesophageal echocardiography (TEE) is usually
recommended in the evaluation of the patent foramen ovale (PFO).
Our goal is to conﬁrm the eﬃcacy of contrast-enhanced transcranial
Doppler (ce-TCD) in detecting residual signiﬁcant right-to-left shunts
(RLS) after PFO percutaneous closure. Materials and methods – Sixty-
eight patients with a previous transient ischemic attack, stroke and a
large PFO were investigated for residual RLS after percutaneous
closure. Results – Assuming TEE as the gold standard, the sensitivity
and negative predictive value of ce-TCD was 100%, whereas the
speciﬁcity was 75.8% and the positive predictive value was
28%. Conclusions – ce-TCD appears to be the preferable technique to
identify subjects with signiﬁcant residual shunts after percutaneous
closure of a PFO. In follow-up, if ce-TCD is negative, no further
examination may be necessary; whereas if ce-TCD shows a residual
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257excursion of the IAS during the respiratory cycle of
more than 10 mm in total amplitude.
Color Doppler helped to detect a shunt through
the IAS, and to identify multiple sites, but the ﬁnal
diagnosis of RLS rested on the contrast injection
technique. Brieﬂy, 10 ml of a solution consisting of
agitated saline (5 ml), blood (4 ml), and air (1 ml)
was injected into a brachial vein at rest and during
the strain phase of the valsalva maneuver (VM);
the patients were asked to let go only when the
right atrium was fully opaciﬁed.
Criteria for patency of the foramen ovale were
based on ﬁnding contrast in the left atrium (LA)
within three cardiac cycles after full right atrium
opaciﬁcation, and were categorized as follows:
absent (when no microbubbles were seen in the
LA either at rest or after Valsalva); not signiﬁcant
(when less than 10 microbubbles passed into the LA
after VM); moderately positive (when 10–20 micro-
bubbles passed in the LA only after VM); strongly
positive (when more than 20 microbubbles were
detected in the LA after valsalva or if microbubbles
were observable at rest). Strongly positive results
were deemed indicative of a large PFO (11, 12).
On TEE, 23 patients (34%) had an ASA; the
shunt was large in 61 (90%); 62 (91%) had either a
large shunt or an ASA.
ce-TCD technique
By means of a DWL Multi-Dop machine (Compu-
medics, Singen, Germany), a bilateral ce-TCD with
two 2-MHz probes installed on a special headset
(LAM rack) was performed. After a basal exam-
ination of the anterior, middle, and posterior
cerebral arteries by TCD, the ce-TCD test was
performed in three steps:
1. VM alone.
2. Contrast injection alone: 10 ml of a mixture of
agitated saline (5 ml), blood (4 ml), and air
(1 ml; same composition as in TEE examin-
ations) was injected into the right antecubital
vein while the Doppler signal from both the
right and the left middle cerebral artery (MCA)
was recorded during normal breathing.
3. Contrast injection during the VM: the mixed
solution was injected 5 s after the patient was
asked to begin pushing; the sequence was
repeated if the number of microembolic signals
(MES) was low ⁄absent.
Any MES recorded 5–12 s after the injection were
considered indicative of an RLS at the atrial level;
if they occurred later, a pulmonary atrium-
ventricular ﬁstula was suspected.
For the quantitative assessment of the amount of
RLS, we followed the classiﬁcation proposed by
Serena et al. (12): small (less than 10 microbubbles)
and large (10 microbubbles or more) shunts with
further subdivision of large shunts in shower
(more than 25 microbubbles) and curtain
(uncountable signals) patterns.
Statistical analysis
TEE served as the reference standard (13). Sensi-
tivity was determined as the percentage of true-
positive ﬁndings (RLS by both methods) compared
with true-positive plus false-negative ﬁndings
(ce-TCD negatives but TEE positives). Speciﬁcity
was calculated as the percentage of true-negative
ﬁndings (no RLS by both methods) compared with
true-negative plus false-positive ﬁndings (ce-TCD
positives but TEE negatives).
The positive predictive value was determined as
the percentage of true-positive ﬁndings compared
with true- plus false-positive ﬁndings. The negative
predictive value was determined as the percentage
of true-negative ﬁndings compared with true- plus
false-negative ﬁndings. Diagnostic accuracy was
calculated as the percentage of true-positive plus
true-negative ﬁndings compared with the total
number of patients examined.
Results
From November 1997 to December 2006, 86
patients with a previous transient ischemic attack
(TIA), or stroke, and a PFO have been submitted
to transcatheter closure. All had a complete
neurological and cardiological assessment: history
and physical evaluation, computed tomography or
magnetic resonance study of the brain and intra-
cranial arteries, echo-Doppler investigation of the
carotid and vertebral arteries, electrocardiogram,
transthoracic, and TEE. Patients with coagulation
abnormalities, vasculitis, atrial ﬁbrillation, mitral
valve disease, marked left ventricular dilatation or
aneurysm, and soft atheromas of the aorta were
excluded.
We recommended percutaneous closure of the
PFO if a patient fulﬁlled any of the following
conditions: (i) age less than 55 years; (ii) a large
RLS (spontaneous, or more than 20 microbubbles
upon valsalva, as detected by a ce-TCD exami-
nation), or presence of an ASA; (iii) anticoagulant
therapy was unsuitable or had already failed;
(iv) more than one stroke ⁄TIA had already
occurred (1, 14). After the procedure, prophylaxis
against bacterial endocarditis and antiplatelet
therapy was recommended for 6 months.
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12 months and yearly thereafter. All patients were
invited to have a TEE within 6 months; 10 refused.
Of the remaining 76, 5 declined to have the
ce-TCD. Of the 71 subjects in whom the ce-TCD
was attempted, no signal could be obtained from
either MCA owing to poor acoustic windows in 3
(4.2%), thus leaving 68 patients with both the TEE
and ce-TCD studies. All patients signed a consent
form for the procedures. The study received the
approval from the local ethical committee.
A total of 38 men and 30 women were studied.
Their mean age was 49  13 years: 45 (66%) were
less than 55 years old. Thirty-four patients had
suﬀered a stroke and 34 a TIA. More than one
event had occurred in 16 (23.5%). Migraine with
aura was present in seven cases (10%).
Computed tomography or magnetic resonance
imaging conﬁrmed a cerebral ischemic lesion in 65
(95%). Risk factors for cerebrovascular diseases
were: hypercholesterolemia in 25 (37%), hyperten-
sion in 21 (31%), current cigarette smoking in 16
(26%), and diabetes in 2 (3%). The investigations
were well tolerated by all the subjects without side
eﬀects.
As shown in Table 1, following the classiﬁcation
based on the TEE criteria, only six patients had a
large (more than 20 microbubbles) residual RLS.
The result was moderately positive (11–20 micro-
bubbles) in two. The shunt was absent or non-
signiﬁcant (0–10 microbubbles) in 60.
By ce-TCD, no RLS or a small one (less than 10
microbubbles) was detected in 37 (54.4%) of the 68
patients. The RLS was large in 10 (14.7%)
patients; 12 (17.7%) had a curtain pattern and 9
(13.2%) a shower pattern.
The eight strongly and moderately positive TEE
results were correctly identiﬁed by either a curtain
or a shower pattern at ce-TCD. However, among
the 60 TEE studies with absent or non-signiﬁcant
ﬁndings (0–10 microbubbles), there were six
shower and seven curtain patterns.
However, all of the 47 cases with less than 25
microbubbles were identiﬁed by ce-TCD as either
closed or with a non-signiﬁcant RLS at TEE.
However, of the 21 shower and curtain patterns
identiﬁed by ce-TCD, 13 were recorded by TEE as
showing no or non-signiﬁcant RLS.
We then compared the aforementioned ﬁndings
in a dichotomic way: the TEE was classiﬁed as
positive when the RLS was large (more than 20
microbubbles) and the ce-TCD results were con-
sidered positive only when a shower or curtain
pattern was observed (Table 2).
Assuming TEE as the gold standard, the sensi-
tivity was 100% (conﬁdence interval: 60.9–100%);
the speciﬁcity was 75.8% (conﬁdence interval:
63.9–84.8%); the positive predictive value was
28.5%; the negative predictive value was 100%;
and the diagnostic accuracy was 77.9%.
Discussion
Percutaneous transcatheter closure of the foramen
ovale is being increasingly employed as a way of
preventing recurrences of stroke of undetermined
cause, although proof is lacking of its superiority
compared with anticoagulant or antiaggregant
therapy (15, 16). The rationale of this solution
resides in the abolition of any RLS across the IAS,
as the postulated mechanism is that of a paradox-
ical embolism (17). However, this goal is not
always achieved.
In a consecutive series of 68 patients following
transcatheterclosureofPFO,wefoundthatce-TCD
revealed a higher number of patients with a residual
RLS compared with TEE. A curtain or shower
pattern was recorded in 21 (30.9%): of these 12
patients, only 6 were classiﬁed as large by TEE. The
percentage of patients with residual RLS of any size
that was found by TEE (22 ⁄68; 32%) was similar to
the 27% reported by Windecker (4).
A residual shunt by TEE has been reported to
range from 0% (18, 19) to 49% (20), with most of
the other studies varying between 2% and 34%
(4, 5, 11, 21–26). However, these results cannot be
Table 1 Cross table of the classification of 68 patients by transesophageal
echocardiography (TEE) and contrast-enhanced transcranial Doppler (ce-TCD; mb
indicates the number of microbubbles)
TEE
Total >20 mb 11–20 mb 0–10 mb
ce-TCD
Curtain 5 7 12
Shower 1 2 6 9
10–25 mb 10 10
0–10 mb 37 37
Total 6 2 60 68
Table 2 Contingency table of the classification of the patients as having a
residual right-to-left shunt (RLS; positive) and without a residual RLS (negative).




Positive 6 15 21
Negative 0 47 47
Total 6 62 68
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methods and criteria adopted, as gleaned from a
brief review of the pertinent literature. No criteria
of RLS were given in three papers (4, 18, 24); color
Doppler was used in two (21, 23); echocontrast in
seven, of which: three (11, 19, 22) adopted a three-
grade scale (0, 3–20, >20 microbubbles); four
adopted Websterss (27) four-grade classiﬁcation
(5, 26) or a variant of it (20). Finally, Schwerzmann
(25) employed Schuchlenzs (28) descriptive assess-
ment (minimal, cloud, and intense).
Anzola et al. (9) reported 8% of residual shunt
by ce-TCD at 6 months, whereas Spencer et al.
(29) found 34% of incomplete closure, as measured
by power M-mode ce-TCD.
According to the report of the Therapeutics and
Technology Assessment Subcommittee of the
American Academy of Neurology (7), ce-TCD is
comparablewithcontrastTEEfordetectingRLSas
a result of PFO. Belvis et al. (8) have reported
almost perfect concordance between the twotech-
niques. Recently, other researchers demonstrated a
statistical correlation between the results obtained
by the two techniques, with reliable concordance
(30–32).
Anzola (9) has suggested that ce-TCD is superior
to TEE in the detection of residual RLS, even
though this suggestion is still debated (33). Resi-
dual shunt has been indicated in recurrent cere-
brovascular accidents following percutaneous
closure by Windecker et al. (4), and some authors
have reported the implantation of a second device
in such patients (34).
It is thus important not only to detect, but also to
quantify a residual RLS. Anzola (9) has proposed
that the number of microbubbles greater than 12
detected by ce-TCD at 3 months could be adopted
as a cut-off value for prediction of failure. Schwerz-
mann et al. (25) have taken a more than minimal
residual shunt by TEE [i.e., a cloud of bubbles or
intense opaciﬁcation of the left atrium, as originally
deﬁned by Schuchlenz et al. (28)] as a reason for
proposing the re-closure of the leaking PFO.
As recently conﬁrmed by Zito et al. (30) and
Kobayashi et al. (35), ce-TCD is a safe and
low-cost investigation technique, which provides
sensitivity and speciﬁcity comparable with ce-TEE.
Our data showed that if ce-TCD is negative, then
no further investigation is necessary, given the high
sensitivity of ce-TCD. Our results are conﬁrmatory
of the ce-TCD performance in PFO detection.
However, our study is speciﬁc of a selected
population of patients who underwent PFO
closure. In our clinical experience, we plan to use
ce-TCD as a PFO-monitoring tool over time,
recommending ce-TEE examination when in pres-
ence of a positive ce-TCD. Mangiaﬁco et al. (31)
underlinedthatce-TCDandce-TEEcanbethought
of as complementary. We agree that the two
methodologiescanprovidecomplementaryinsights,
asce-TEEremainspreferableindeterminingthesize
of residual RLS in patient follow-up.
In summary, we have found that ce-TCD is
preferable to TEE to detect residual RLS after
transcatheter closure of a PFO. The discomfort is
much less, the VM can be performed with more
reliability (14), and a suitable signal can almost
always be obtained: our failure rate was 4.2%,
compared with Serena et al.s (13) 18.9%.
Conclusions
ce-TCD appears to be the preferable technique to
identify subjects with signiﬁcant residual shunts
after percutaneous closure of a PFO, also as a
result of a lower discomfort to the subjects and the
possibility of performing a better VM. Our data
showed that, in patient follow-up, if ce-TCD is
negative, no further examination may be necessary;
if ce-TCD shows a residual shunt, it is advisable to
perform a TEE investigation.
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